Back
Oncternal Therapeutics Stock Price Chart
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Sell
37
ONCT
Oncternal Therapeutics
Last Price:
8.39
Seasonality Move:
0.33%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Oncternal Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.6 | Sell |
| 20-day SMA: | 8.8 | Sell |
| 50-day SMA: | 8.84 | Sell |
| 200-day SMA: | 7.78 | Buy |
| 8-day EMA: | 8.54 | Sell |
| 20-day EMA: | 8.67 | Sell |
| 50-day EMA: | 8.73 | Sell |
| 200-day EMA: | 9.15 | Sell |
Oncternal Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 44.16 | Sell |
| Chaikin Money Flow: | 1441 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.33 - 9.09) | Sell |
| Bollinger Bands (100): | (7.71 - 9.93) | Sell |
Oncternal Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oncternal Therapeutics Stock
Is Oncternal Therapeutics Stock a Buy?
- Oncternal Therapeutics share price is 8.29 while ONCT 8-day simple moving average is 8.60, which is a Sell signal.
- The stock price of ONCT is 8.29 while Oncternal Therapeutics 20-day SMA is 8.80, which makes it a Sell.
- Oncternal Therapeutics 50-day simple moving average is 8.84 while ONCT share price is 8.29, making it a Sell technically.
- ONCT stock price is 8.29 and Oncternal Therapeutics 200-day simple moving average is 7.78, creating a Buy signal.
ONCT Technical Analysis vs Fundamental Analysis
Sell
37
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics a Buy or a Sell?
-
Oncternal Therapeutics stock is rated a Sell
The current Oncternal Therapeutics [ONCT] share price is $8.29. The Score for ONCT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Oncternal Therapeutics Stock Info
Market Cap:
24.54M
Price in USD:
8.29
Share Volume:
1.44K
Oncternal Therapeutics 52-Week Range
52-Week High:
13.14
52-Week Low:
5.57
Sell
37
Oncternal Therapeutics (ONCT)
is a Sell
Oncternal Therapeutics Share Price Forecast
-
What is the Oncternal Therapeutics stock price today?
The Oncternal Therapeutics stock price is 8.29 USD today. -
Will ONCT stock go up or go down?
Oncternal Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Oncternal Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oncternal Therapeutics is overvalued.
Is Oncternal Therapeutics Stock a Buy?
- Oncternal Therapeutics share price is 8.29 while ONCT 8-day exponential moving average is 8.54, which is a Sell signal.
- The stock price of ONCT is 8.29 while Oncternal Therapeutics 20-day EMA is 8.67, which makes it a Sell.
- Oncternal Therapeutics 50-day exponential moving average is 8.73 while ONCT share price is 8.29, making it a Sell technically.
- ONCT stock price is 8.29 and Oncternal Therapeutics 200-day simple moving average is 9.15, creating a Sell signal.
Fundamental Analysis of Oncternal Therapeutics
Is Oncternal Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.73 per share, and a decrease next year of $0.56 per share.
Technical Analysis of Oncternal Therapeutics
Should I short Oncternal Therapeutics stock?
- ONCT Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Oncternal Therapeutics is a Sell
- Oncternal Therapeutics Relative Strength Index (RSI) is 44.16, which suggest Oncternal Therapeutics is oversold
- The Bollinger Bands (25) for Oncternal Therapeutics is (8.33 - 9.09), which suggest Oncternal Therapeutics is a Sell
- The Bollinger Bands (100) for Oncternal Therapeutics is (7.71 - 9.93), which suggest Oncternal Therapeutics is a Sell
* Oncternal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.